Cogent Biosciences (COGT) Return on Sales (2017 - 2020)
Historic Return on Sales for Cogent Biosciences (COGT) over the last 5 years, with Q2 2021 value amounting to 219.75%.
- Cogent Biosciences' Return on Sales fell 2057300.0% to 219.75% in Q2 2021 from the same period last year, while for Jun 2021 it was 219.75%, marking a year-over-year decrease of 2187700.0%. This contributed to the annual value of 10.42% for FY2020, which is 90100.0% down from last year.
- Cogent Biosciences' Return on Sales amounted to 219.75% in Q2 2021, which was down 2057300.0% from 90.43% recorded in Q1 2021.
- In the past 5 years, Cogent Biosciences' Return on Sales ranged from a high of 0.15% in Q4 2019 and a low of 219.75% during Q2 2021
- Its 5-year average for Return on Sales is 31.43%, with a median of 3.59% in 2019.
- In the last 5 years, Cogent Biosciences' Return on Sales surged by 29600bps in 2020 and then tumbled by -2057300bps in 2021.
- Cogent Biosciences' Return on Sales (Quarter) stood at 3.19% in 2017, then rose by 29bps to 2.26% in 2018, then soared by 107bps to 0.15% in 2019, then plummeted by -7026bps to 10.42% in 2020, then tumbled by -2008bps to 219.75% in 2021.
- Its last three reported values are 219.75% in Q2 2021, 90.43% for Q1 2021, and 10.42% during Q4 2020.